Grünenthal Group
Mauro Marigo currently serves as the Head of Chemistry at Grünenthal Group since May 2022, following a tenure as Vice-President of Medicinal Chemistry at Endogena Therapeutics, Inc. from July 2019 to April 2022. Prior to that, Mauro held various roles at Lundbeck from November 2008 to June 2019, including Senior Principal Scientist and FBDD Specialist. Mauro's career began at Nuevolution from July 2006 to October 2008 as a Research Scientist and Project Manager. Educational qualifications include a Postdoctoral degree in Chemistry and a Ph.D. in Organic Chemistry from Aarhus University, complemented by an M.Sc. in Chemistry from Università degli Studi di Trieste.
This person is not in any teams
This person is not in any offices
Grünenthal Group
5 followers
Grünenthal is a global leader in pain management and related diseases. As a science-based privately-owned pharmaceutical company, they have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide.